Member Info for JackoDLad

Oh Gaza how wrong you are. Where do I apply for the 10 pence for my post. I am a very legitimate PI and have been invested here since the 2.6p days.
I feel it is unfortunate that appropriate questions are accused in this way but it shouts more about the accusers.
Thx to Ian, who at least tried to give me an answer to my legitimate question.
GLAGI

Very helpful, thx. So you don't know either then. You might have just said that........

Still makes no sense. Why would a nickel miner let a humongous nickel resource like this go to a competitor? I'm genuinely asking.

I'm referring to CeeJay post at 13:40 "NKT, a nickel mine formerly operated by Norilsk Nickel". Why would NN let the NKT nickel mine go to Eua? Doesn't make sense to me. Anyone help?

Can anyone advise why Norilsk Nickel let this nickel mine go to Eurasia? I understand they did the same before with their PGM explorations but that was at a time when PGM prices were lower than the extraction costs, so made no financial sense. I'm just wondering why they let a nickel mine go?

Seemed fairly innocuous to me!

:) to you SB

Much Ado About Nought

"Eats, shoots and leaves" was a very good book - all about the use of punctuation.
GLA

A year ago the sp was 8.32p.

So I would estimate mcap as 81m.
JDL

Not being funny, and really good news, but is this not an update on a competitor to Hemo?

Just use the filter feature to weed out the weeds.

HMN is in its pre commercial phase (ie not revenue generating). There is some cash for commercialisation of its research pipeline but there is still a lot of unproven risk. This is all priced into the current SP. There was a spike last year due to the Covid bounce everywhere in the pharma plays but this spike has long since deflated, and HMN is now trading in its pre Covid range of 1-2p once again. It will continue to do so until the pipelines commercialise.

https://www.ft.com/content/30415edc-1643-4334-a381-96ede6d88e2c

to the admin for removing those irrelevant posts....

Wat a lot of boiler room b.s........

Seems nice and sticky

that this RNS was leaked yesterday, allowing shorters an early exit.
GLAGI

Ah no, not another nautical meme :)
GLAGI

Yes, agreed, the patent approval is recent but wouldn't be of significant value. Bigger value is how Vlad manages the patent IP into revenue generation. In that context 1-2p is cheap and very much a punt. My point is the track record points the other direction. Time will tell.
GLAGI